Published by
@ShahidNShah
@ShahidNShah
The 5th Cytokine-Based Drug Development Summit 2024, held from May 21-23, heralds a new phase in cytokine therapies. Leading developers employ cutting-edge technologies and novel targets to surmount efficacy and toxicity hurdles, expanding disease focus. This pivotal industry summit integrates past insights, offering a disease-agnostic perspective. With a curated agenda spanning oncology, autoimmune, and infectious diseases, this 3-day event stands as the singular industry-driven platform for cytokine research. Amidst enhanced translational knowledge and technology, it strives to bring life-changing drugs to patients, emphasizing the reinvigorated potential in the cytokine landscape.
[Read on cytokine-based-drugdevelopment](https://cytokine-based-drugdevelopment.com/)
Continue reading at cytokine-based-drugdevelopment.com
May 23 to May 24, 2024
Revere Hotel Boston Common, 200 Stuart Street, Boston, Massachusetts, 02116, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am